Endocyte (ECYT)
Add to Watchlists Create an Alert
14.02
+0.23 +1.67%
NASDAQ
May 23, 4:59PM
BATS Real time
Currency in USD
Endocyte Revenue TTM:
49.20M for Dec. 31, 2012Endocyte Historical Revenue TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 49.20M |
| Dec. 31, 2012 | 34.68M |
| Sept. 30, 2012 | 20.42M |
| June 30, 2012 | 8.004M |
| March 31, 2012 | 0.191M |
| Dec. 31, 2011 | 0.191M |
| Sept. 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | 0.00 |
| Sept. 30, 2010 | 0.00 |
| June 30, 2010 | 3.00M |
About Revenues (TTM)
ECYT Revenue TTM Benchmarks
| Companies | |
|---|---|
| Lannett Company | 138.24M |
| Merck | 46.21B |
| Catalyst Pharmaceutical Partners | 0.00 |
ECYT Revenue TTM Rankings
| Overall |
52nd percentile 3804 of 8006 |
| Sector |
57th percentile 290 of 686 in Healthcare |
| Industry |
57th percentile 29 of 68 in Drug Manufacturers - Specialty & Generic |
ECYT Revenue TTM Range, Past 5 Years
| Minimum | 0.00 | Sep 2010 |
| Maximum | 49.20M | Mar 2013 |
| Average | 9.640M |